Statistics from Altmetric.com
To the Editor Having read the three papers published on the Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial,1–3 I have come to the conclusion that there has been a major miscarriage of justice. That miscarriage of justice relates to diagnostic equipment used in the standard treatment protocols for the hospitals involved in the RATPAC trial (Beckman Access, Centaur CP and Roche E170). The point-of-care testing (POCT) was not convincingly vindicated in this trial but the other equipment and methods were deemed by association of the data to be inadequate. A cursory examination of …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.